首页> 美国卫生研究院文献>Cancer Science >Organ‐specific Modification of Tumor Development by Low‐dose Combinations of Agents in a Rat Wide‐spectrum Carcinogenesis Model
【2h】

Organ‐specific Modification of Tumor Development by Low‐dose Combinations of Agents in a Rat Wide‐spectrum Carcinogenesis Model

机译:低剂量组合剂在大鼠广谱致癌模型中对肿瘤发育的器官特异性修饰

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The combined effects of low doses of various carcinogens and carcinogenesis modifiers on tumor development were investigated by using a wide‐spectrum organ carcinogenesis model in F344 rats. These agents were administered as three groups: (1) a group of known hepatocarcinogens; (2) a group of nitroso compounds having various target organ specificities; and (3) a group of antioxidants having various inhibiting or enhancing activities depending on the target organ. Doses were used which were generally below the known effective level for the individual chemical. These groups of chemicals were administered with or without prior administration of N‐diethylnitrosamine (100 mg/kg body wt., i.p.), N‐methylnitrosourea (4 × 20 mgAg body wt., i.p.) and dihydroxy‐di‐N‐propylnitrosamine (0.1% in drinking water for 2 weeks). The hepatocarcinogen group in combination with various nitroso compounds increased the incidences of liver hyperplastic nodules and hepatocellular carcinomas. In contrast, incidences were clearly reduced when the hepatocarcinogens and/or the nitroso compounds were administered in combination with the antioxidants. For the urinary bladder, the combination with nitroso compounds and antioxidants enhanced cancer development, and the addition of hepatocarcinogens further increased tumorigenesis. For the glandular stomach, additive effects on the numbers of pepsinogen isozyme 1‐altered pyloric glands, a putative preneoplastic lesion, were produced by the combination treatment of antioxidants and the nitroso compounds. No synergistic effects on tumor development were seen in other organs. The results of the present study demonstrated that combinations of various compounds at low doses can additively or synergistically exert either enhancing or inhibitory effects on the development of preneoplastic and neoplastic lesions in different organs in a single model having a wide spectrum of organ effects.
机译:使用广谱器官癌变模型在F344大鼠中研究了低剂量的各种致癌物和致癌修饰剂对肿瘤发展的联合作用。这些药物分为三组:(1)一组已知的肝致癌物; (2)一组具有各种靶器官特异性的亚硝基化合物; (3)一组根据靶器官具有各种抑制或增强活性的抗氧化剂。使用的剂量通常低于单个化学品的已知有效水平。这些组的化学品在使用或不使用N-二乙基亚硝胺(100 mg / kg体重,ip),N-甲基亚硝基脲(4×20 mgAg体重,ip)和二羟基-二-N-丙基亚硝胺(ip在0.1%的饮用水中放置2周)。肝癌原基与各种亚硝基化合物的结合会增加肝增生性结节和肝细胞癌的发生率。相反,当将肝癌致癌物和/或亚硝基化合物与抗氧化剂组合使用时,发病率明显降低。对于膀胱而言,与亚硝基化合物和抗氧化剂的组合可增强癌症的发展,而添加肝致癌物则进一步增加了肿瘤的发生。对于腺胃,通过抗氧化剂和亚硝基化合物的联合处理,对胃蛋白酶原同工酶1改变的幽门腺(一种假定的肿瘤前病变)的数量产生累加效应。在其他器官中未观察到对肿瘤发展的协同作用。本研究的结果表明,在具有广泛器官效应的单一模型中,低剂量各种化合物的组合可在不同器官中对不同器官的前肿瘤和肿瘤性病变的发展加成或协同地发挥增强或抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号